Skip to search.
 FTSE 100 Down 1.03%

Kite Pharma, Inc. (KITE)

-NasdaqGS
55.65 Up 0.53(0.95%) 19:17 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:55.12
Open:55.20
Bid:55.78 x 100
Ask:55.89 x 100
1y Target Est:83.17
Beta:N/A
Next Earnings Date:N/A
Day's Range:52.52 - 57.14
52wk Range:21.00 - 89.21
Volume:894,070
Avg Vol (3m):1,153,370
Market Cap:2.37b
P/E (ttm):N/A
EPS (ttm):-1.91
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KITEUp 0.95%2.37b
CELGDown 1.19%90.75b
NVSUp 0.18%249.70b
PFEDown 0.98%210.31b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.74
Quarterly EPS Est (Mar-15) :0.28
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback